AGIOS PHARMACEUTICALS INC's ticker is AGIO and the CUSIP is 00847X104. A total of 152 filers reported holding AGIOS PHARMACEUTICALS INC in Q3 2015. The put-call ratio across all filers is 0.86 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $3,739,000 | +381.8% | 48,485 | +229.8% | 0.13% | +371.4% |
| Q3 2016 | $776,000 | +26.0% | 14,700 | 0.0% | 0.03% | +27.3% |
| Q2 2016 | $616,000 | -61.7% | 14,700 | -62.9% | 0.02% | -62.1% |
| Q1 2016 | $1,609,000 | -37.5% | 39,640 | 0.0% | 0.06% | -30.1% |
| Q4 2015 | $2,573,000 | -83.3% | 39,640 | -81.9% | 0.08% | -83.5% |
| Q3 2015 | $15,449,000 | -10.2% | 218,855 | +41.4% | 0.50% | +3.1% |
| Q2 2015 | $17,199,000 | – | 154,755 | – | 0.49% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Rock Springs Capital Management LP | 2,661,605 | $61,137,067 | 1.46% |
| Bellevue Group AG | 4,013,500 | $92,190,095 | 1.34% |
| Eagle Health Investments LP | 267,630 | $6,147,461 | 1.20% |
| ARMISTICE CAPITAL, LLC | 3,460,000 | $79,476,200 | 1.14% |
| Integral Health Asset Management, LLC | 213,000 | $4,892,610 | 0.99% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 454,000 | $10,428,380 | 0.44% |
| ArrowMark Colorado Holdings LLC | 1,557,705 | $35,780,484 | 0.41% |
| FARALLON CAPITAL MANAGEMENT LLC | 2,092,829 | $48,072,282 | 0.27% |
| Virtus ETF Advisers LLC | 9,932 | $228,138 | 0.13% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 614,533 | $14,115,823 | 0.09% |